药物研发中的药代动力学和药效学建模 - Suppr

Suppr

超能文献

Pharmacokinetic and pharmacodynamic modelling in drug development.

作者信息

Aarons L

出版信息

Stat Methods Med Res. 1999 Sep;8(3):181-2. doi: 10.1177/096228029900800301.

DOI:10.1177/096228029900800301

PMID:10636333

Abstract

摘要

相似文献

Pharmacokinetic and pharmacodynamic modelling in drug development.

Stat Methods Med Res. 1999 Sep;8(3):181-2. doi: 10.1177/096228029900800301.

A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.

Stat Methods Med Res. 1999 Sep;8(3):217-45. doi: 10.1177/096228029900800304.

Population modelling in drug development.

Stat Methods Med Res. 1999 Sep;8(3):183-93. doi: 10.1177/096228029900800302.

Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.

Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1599-604. doi: 10.1517/17425255.2010.529899. Epub 2010 Oct 24.

Pharmacokinetic/pharmacodynamic modeling in drug development.

Annu Rev Pharmacol Toxicol. 2000;40:67-95. doi: 10.1146/annurev.pharmtox.40.1.67.

PK/PD modelling and simulations: utility in drug development.

Drug Discov Today. 2008 Apr;13(7-8):341-6. doi: 10.1016/j.drudis.2008.01.003. Epub 2008 Mar 7.

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

Clin Pharmacokinet. 1998 Aug;35(2):151-66. doi: 10.2165/00003088-199835020-00004.

Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm.

Clin Pharmacokinet. 1997 Apr;32(4):259-67. doi: 10.2165/00003088-199732040-00001.

Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.

Drug Discov Today. 2011 Dec;16(23-24):1031-6. doi: 10.1016/j.drudis.2011.10.001. Epub 2011 Oct 13.

Pharmacokinetic/pharmacodynamic modeling in drug research and development.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1399-418.

引用本文的文献

Stochastic nonlinear mixed effects: a metformin case study.

J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):85-98. doi: 10.1007/s10928-015-9456-7. Epub 2015 Nov 19.

A matlab framework for estimation of NLME models using stochastic differential equations: applications for estimation of insulin secretion rates.

J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):623-42. doi: 10.1007/s10928-007-9062-4. Epub 2007 Jun 15.

Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm.

J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):85-107. doi: 10.1007/s10928-005-2104-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Pharmacokinetic and pharmacodynamic modelling in drug development.

Stat Methods Med Res. 1999 Sep;8(3):181-2. doi: 10.1177/096228029900800301.

A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.

Stat Methods Med Res. 1999 Sep;8(3):217-45. doi: 10.1177/096228029900800304.

Population modelling in drug development.

Stat Methods Med Res. 1999 Sep;8(3):183-93. doi: 10.1177/096228029900800302.

Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.

Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1599-604. doi: 10.1517/17425255.2010.529899. Epub 2010 Oct 24.

Pharmacokinetic/pharmacodynamic modeling in drug development.

Annu Rev Pharmacol Toxicol. 2000;40:67-95. doi: 10.1146/annurev.pharmtox.40.1.67.

PK/PD modelling and simulations: utility in drug development.

Drug Discov Today. 2008 Apr;13(7-8):341-6. doi: 10.1016/j.drudis.2008.01.003. Epub 2008 Mar 7.

Methodological issues in pharmacokinetic-pharmacodynamic modelling.

Clin Pharmacokinet. 1998 Aug;35(2):151-66. doi: 10.2165/00003088-199835020-00004.

Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development. The "wooden shoe' paradigm.

Clin Pharmacokinet. 1997 Apr;32(4):259-67. doi: 10.2165/00003088-199732040-00001.

Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.

Drug Discov Today. 2011 Dec;16(23-24):1031-6. doi: 10.1016/j.drudis.2011.10.001. Epub 2011 Oct 13.

Pharmacokinetic/pharmacodynamic modeling in drug research and development.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1399-418.

引用本文的文献

Stochastic nonlinear mixed effects: a metformin case study.

J Pharmacokinet Pharmacodyn. 2016 Feb;43(1):85-98. doi: 10.1007/s10928-015-9456-7. Epub 2015 Nov 19.

A matlab framework for estimation of NLME models using stochastic differential equations: applications for estimation of insulin secretion rates.

J Pharmacokinet Pharmacodyn. 2007 Oct;34(5):623-42. doi: 10.1007/s10928-007-9062-4. Epub 2007 Jun 15.

Non-linear mixed-effects models with stochastic differential equations: implementation of an estimation algorithm.

J Pharmacokinet Pharmacodyn. 2005 Feb;32(1):85-107. doi: 10.1007/s10928-005-2104-x.